Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.
暂无分享,去创建一个
J R Chretien | G Folkers | H. van de Waterbeemd | G. Folkers | J. Chrétien | G Camenisch | H van de Waterbeemd | G. Camenisch | O. Raevsky | O A Raevsky | Gerd Folkers | Han van de Waterbeemd | Gian Camenisch
[1] M. Abraham,et al. On the partition of ampholytes: application to blood-brain distribution. , 1997, Journal of pharmaceutical sciences.
[2] J. Hawkinson,et al. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor. , 1997, Journal of medicinal chemistry.
[3] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[4] F. Lombardo,et al. Computation of brain-blood partitioning of organic solutes via free energy calculations. , 1996, Journal of medicinal chemistry.
[5] G Folkers,et al. Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.
[6] K. Nakamura,et al. Thermodynamic aspects of hydrophobicity and the blood-brain barrier permeability studied with a gel filtration chromatography. , 1996, Journal of medicinal chemistry.
[7] K. Marsh,et al. Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption. , 1996, Journal of medicinal chemistry.
[8] D. Begley,et al. The Blood‐brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System , 1996, The Journal of pharmacy and pharmacology.
[9] Han van de Waterbeemd,et al. Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors , 1996 .
[10] K. Luthman,et al. Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.
[11] Harpreet S. Chadha,et al. Hydrogen-bonding. Part 36. Determination of blood brain distribution using octanol-water partition coefficients. , 1995, Drug design and discovery.
[12] P. Borst,et al. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.
[13] Peter L. Bonate,et al. Animal models for studying transport across the blood-brain barrier , 1995, Journal of Neuroscience Methods.
[14] Hugo Kubinyi,et al. The Physicochemical Significance of Topological Parameters. A Rebuttal , 1995 .
[15] Oleg A. Raevsky,et al. H-BOND CONTRIBUTION TO OCTANOL-WATER PARTITION COEFFICIENTS OF POLAR COMPOUNDS , 1995 .
[16] Bernard Testa,et al. Lipophilicity and hydrogen-bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects , 1994 .
[17] Harpreet S. Chadha,et al. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. , 1994, Journal of pharmaceutical sciences.
[18] C R Ganellin,et al. Predicting the brain-penetrating capability of histaminergic compounds. , 1994, Drug design and discovery.
[19] P. Leeson,et al. 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor. , 1994, Journal of medicinal chemistry.
[20] D. Barlow,et al. The design of peptide analogues for improved absorption , 1994 .
[21] A. Seelig,et al. A method to determine the ability of drugs to diffuse through the blood-brain barrier. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] Michael H. Abraham,et al. Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes , 2010 .
[23] R. Broadwell. Transcytosis of Macromolecules through the Blood—Brain Fluid Barriers in Vivo , 1993 .
[24] W. Pardridge,et al. Brain drug delivery and blood–Brain barrier transport , 1993 .
[25] M. Kansy,et al. Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).
[26] Bernard Testa,et al. Polar intermolecular interactions encoded in partition coefficients: an indirect estimation of hydrogen-bond parameters of polyfunctional solutes , 1992 .
[27] Oleg A. Raevsky,et al. Complete Thermodynamic Description of H‐Bonding in the Framework of Multiplicative Approach , 1992 .
[28] Donald W. Miller,et al. Brain uptake of drugs : the influence of chemical and biological factors , 1992 .
[29] A. Seelig,et al. Substance P and Antagonists , 1991 .
[30] C G Wermuth,et al. GABA-uptake inhibitors: construction of a general pharmacophore model and successful prediction of a new representative. , 1991, Journal of medicinal chemistry.
[31] W. R. Lieb,et al. Role of hydrogen bonding in general anesthesia. , 1991, Journal of pharmaceutical sciences.
[32] N el Tayar,et al. Partitioning of solutes in different solvent systems: the contribution of hydrogen-bonding capacity and polarity. , 1991, Journal of pharmaceutical sciences.
[33] C. Lipinski,et al. Physical parameters for brian uptake: optimizing log P, log D and pKa of T H A , 1991 .
[34] A. Seelig. Substance P and antagonists. Surface activity and molecular shapes. , 1990, Biochimica et biophysica acta.
[35] S. P. Gupta,et al. QSAR studies on drugs acting at the central nervous system , 1989 .
[36] N. Bodor,et al. A new method for the estimation of partition coefficient , 1989 .
[37] R Griffiths,et al. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.
[38] A. Leo,et al. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. , 1987, Journal of pharmaceutical sciences.
[39] Bernard Testa,et al. The parametrization of lipophilicity and other structural properties in drug design , 1987 .
[40] J. Leysen,et al. Optimal Conditions for [3H]Apomorphine Binding and Anomalous Equilibrium Binding of [3H]Apomorphine and [3H]Spiperone to Rat Striatal Membranes: Involvement of Surface Phenomena Versus Multiple Binding Sites , 1981, Journal of neurochemistry.
[41] P. Seiler,et al. Steric and lipophobic components of the hydrophobic fragmental constant. , 1981, Arzneimittel-Forschung.
[42] V A Levin,et al. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. , 1980, Journal of medicinal chemistry.
[43] G. L. Tong,et al. Structural requirements for centrally acting drugs. I. , 1973, Journal of pharmaceutical sciences.
[44] A. Leo,et al. Partition coefficients and their uses , 1971 .
[45] Merlis Jk. Anatomical and physiological aspects. , 1954 .